Hypoglycemia

The majority of adults with diabetes say their diabetes team has never discussed the topic of mental health with them, even though most self-reported feelings of emotional distress, according to survey data published in Diabetic Medicine.

The FDA has updated the label for Ozempic to include the potential risk for ileus, or an intestinal blockage, as well as increased risk for hypoglycemia if used in combination with insulin or insulin secretagogue.

Adults with type 1 diabetes and impaired awareness of hypoglycemia have worse diabetes-related distress than those with normal hypoglycemia awareness, according to a study published in Diabetic Medicine.

The FDA approved an allogenic pancreatic islet cellular therapy for adults with type 1 diabetes who struggled to achieve their target HbA1c due to repeated episodes of severe hypoglycemia, according to an agency press release.

The FDA has approved new oral therapies for children with type 2 diabetes — empagliflozin and a combination of empagliflozin and metformin hydrochloride — for the first time in more than 20 years.

People with type 2 diabetes who spend more time in glycemic range have lower risks for major adverse cardiovascular events, severe hypoglycemia and microvascular events, according to a post hoc analysis of the DEVOTE trial.

CHICAGO — Children with diabetes and their caregivers use a wide variety of continuous glucose monitoring alarm settings, and usage may differ based on the child’s age, according to a presenter at ENDO 2023.

People with type 1 diabetes using a hybrid closed-loop insulin delivery system are less likely to experience severe hypoglycemia than nonusers, according to study data.

Fewer people with diabetes filled glucagon prescriptions in 2021 compared with 2011, though increases were seen among those with type 1 diabetes and adults with a history of severe hypoglycemia, according to study data.

Researchers highlighted challenges with continuous glucose monitoring devices, including trouble interpreting results, device adhesion and smartphone access, among adults aged 50 to 85 years with type 1 or type 2 diabetes.